SEGMENT INFORMATION

9 Months Ended

Dec. 31, 2011

Segment Reporting [Abstract]

SEGMENT INFORMATION

SEGMENT INFORMATION

Segment Definition Criteria

We manage our business on the basis of one operating segment: the design, manufacture, and marketing of blood management solutions. Our chief operating decision-maker uses consolidated results to make operating and strategic decisions. Manufacturing processes, as well as the regulatory environment in which we operate, are largely the same for all product lines.

Enterprise Wide Disclosures about Product and Services

We have four global product families: plasma, blood center, hospital, and software solutions.

Our products include devices and the disposable single-use sterile kits used with these devices. Disposables include the plasma, blood center, and hospital product families. Plasma consists of the disposables used to perform apheresis for the separation of whole blood components and subsequent collection of plasma to be used as a raw material for biologically derived pharmaceuticals (also known as source plasma). Blood center consists of disposables which separate whole blood for the subsequent collection of platelets, plasma, red cells, or a combination of these components for transfusion to patients. Hospital consists of surgical disposables (principally the Cell Saver^® and Cell Saver Elite ^® autologous blood recovery systems targeted to procedures that involve rapid, high volume blood loss such as cardiovascular surgeries and the cardioPAT^® cardiovascular perioperative autotransfusion system designed to remain with the patient following cardiovascular surgery to recover blood and the patient’s red cells to prepare them for reinfusion), the OrthoPAT^® orthopedic perioperative autotransfusion system designed to operate both during and after orthopedic surgery to recover and wash the patient’s red cells to prepare them for reinfusion, and diagnostics products (principally the TEG^® Thrombelastograph^® hemostasis analyzer used to help assess a surgical patient’s blood clotting ability before, during and after surgery).

Disposable kits are marketed in our plasma, blood center, and hospital product businesses. Plasma disposables are used with our PCS^®2 devices to perform apheresis for the collection of plasma to be used as a raw material for biologically derived pharmaceuticals (also known as source plasma). Blood center disposables are used with our MCS+ device to collect one or more blood components (principally platelets but also red cells and plasma) for transfusion to patients. The Hospital business consists of disposables used with our Cell Saver^® and cardioPAT^® devices to recover red cells from blood lost in a surgical procedure so that these may be made available for reinfusion to the patient (“autotransfusion”). OrthoPAT^® disposables are used for autotransfusion during and immediately following orthopedic surgeries. Diagnostics products principally reflect sales of diagnostic reagents and the TEG^® Thrombelastograph^® hemostasis analyzer which profiles a patient’s blood clotting characteristics.

Software solutions include information technology platforms that assist blood centers, plasma centers, and hospitals to more effectively manage regulatory compliance and operational efficiency.

Revenues from External Customers:

	Three Months Ended
(in thousands)	December 31, 2011		January 1, 2011
Disposable revenues
Plasma disposables	$	69,040	$	59,814
Blood center disposables
Platelet	44,383		41,056
Red cell	12,162		11,676
	56,545		52,732
Hospital disposables
Surgical	17,333		17,116
OrthoPAT	7,755		9,248
Diagnostics	5,681		5,220
	30,769		31,584
Disposables revenue	156,354		144,130
Software solutions	15,849		16,571
Equipment & other	18,957		16,088
Net revenues	$	191,160	$	176,789

	Nine Months Ended
(in thousands)	December 31, 2011		January 1, 2011
Disposable revenues
Plasma disposables	$	196,206	$	172,245
Blood center disposables
Platelet	123,888		117,120
Red cell	35,676		34,284
	159,564		151,404
Hospital disposables
Surgical	49,281		49,479
OrthoPAT	22,804		26,486
Diagnostics	16,955		14,575
	89,040		90,540
Disposables revenue	444,810		414,189
Software solutions	51,208		49,155
Equipment & other	45,156		43,317
Net revenues	$	541,174	$	506,661